A real-world analysis of second-line treatment options in pancreatic cancer: liposomal-irinotecan plus 5-fluorouracil and folinic acid

Markus Kieler,Matthias Unseld,Daniela Bianconi,Werner Scheithauer,Gerald W. Prager

A real-world analysis of second-line treatment options in pancreatic cancer: liposomal-irinotecan plus 5-fluorouracil and folinic acid

2019

Markus Kieler
Matthias Unseld
Daniela Bianconi
Werner Scheithauer
Gerald W. Prager

Background:Nanoliposomal irinotecan (nal-IRI) plus 5-fluorouracil/leucovorin (5-FU/LV) is a novel treatment option for gemcitabine-pretreated metastatic pancreatic adenocarcinoma (PAC) patients, bu...

Keywords:

Irinotecan
Liposomal Irinotecan
Pharmacology
Fluorouracil
Metastatic Pancreatic Adenocarcinoma
Pancreatic cancer
Cancer research
Oxaliplatin
Folinic acid
Medicine
Internal medicine
Oncology
second line treatment

Correction
Source
Cite
Save
Machine Reading By IdeaReader

References

Citations